-
How In Vitro Drug Response Metrics Improve Cancer Studies
2026-08-20
Hannah R. Schwartz’s 2022 dissertation distinguishes relative viability from fractional viability, showing why growth inhibition and cell killing should not be treated as interchangeable drug-response outcomes. The framework supports more informative cancer pharmacology by aligning assay choice, timing, and interpretation with the biological process being measured.
-
Triacetin Workflows for Metabolic and Cell Assays
2026-08-20
Triacetin, or glyceryl triacetate, supports distinct bench applications spanning glioblastoma apoptosis studies, adipogenesis assays, and ocular formulation screening. This practical guide connects concentration selection, formulation control, orthogonal readouts, and troubleshooting for more reproducible experiments.
-
Nitrocefin Assays for β-Lactamase Research
2026-08-19
Nitrocefin converts β-lactamase activity into a rapid yellow-to-red signal, supporting enzyme characterization, resistance profiling, and inhibitor screening. This guide combines practical assay setup with a structure-based peptide-discovery workflow inspired by recent TEM-1 research.
-
InstaBlue Protein Stain Solution for Antibody Gels
2026-08-19
Use InstaBlue Protein Stain Solution to accelerate gel-based quality control during antibody expression, purification, and variant comparison. Its fixation-free, mass-spectrometry-compatible workflow is especially useful when preserving protein integrity matters more than conventional overnight staining.
-
Dabigatran etexilate: Assay Workflow Guide
2026-08-18
Build reproducible thrombin, plasma-clotting, and platelet workflows with Dabigatran etexilate while accounting for its prodrug chemistry and solvent constraints. This guide translates direct thrombin inhibition data into practical assay design, controls, troubleshooting, and atrial fibrillation research applications.
-
X-press Tag Peptide: Purification Guide
2026-08-18
X-press Tag Peptide is an N-terminal leader peptide that combines polyhistidine capture, Xpress epitope recognition, and enterokinase-cleavable design. SKU A6010 supports affinity purification and detection workflows, while the cited RHEB study provides biological context rather than direct validation of this product.
-
N1-Methylpseudouridine for mRNA Translation
2026-08-17
N1-Methylpseudouridine supports high-expression, lower-innate-activation mRNA workflows, with particular value for difficult intracellular proteins such as NPC1. This practical guide connects modified nucleoside selection with codon design, reporter screening, disease-relevant assays, and troubleshooting.
-
DNase I (RNase-free) for Cleaner RNA Workflows
2026-08-17
Improve RNA extraction, RT-PCR, and in vitro transcription sample preparation by removing DNA without introducing ribonuclease activity. This guide combines ion-aware digestion, practical cleanup controls, and troubleshooting for complex samples, including chromatin and RNA:DNA hybrids.
-
Cisplatin and Kidney-Sparing Assay Design
2026-08-16
Cisplatin remains a powerful DNA-damaging tool, but its renal toxicity can complicate interpretation. This guide connects CDDP mechanism, Nrf2 biology, assay design, and translational cancer research to improve efficacy–toxicity analysis.
-
Faropenem sodium: Assay Reliability Guide
2026-08-15
Learn how Faropenem sodium (SKU C8712) can be incorporated into infection-model, viability, proliferation, and cytotoxicity workflows without confusing antibacterial activity with direct mammalian-cell toxicity. This scenario-based guide covers formulation, controls, interpretation, and practical supplier selection using product data and transporter literature.
-
X-press Tag Peptide in RHEB Assay Workflows
2026-08-14
X-press Tag Peptide combines N-terminal affinity capture, epitope-based detection, and enterokinase-release options for recombinant protein workflows. This article shows how to apply that design to RHEB and UBE2F-SAG studies while separating purification convenience from evidence of neddylation or mTORC1 activity.
-
HBsAg–TBK1 Control of Interferon and Autophagy
2026-08-14
The reference study identifies a mechanism by which hepatitis B surface antigen redirects TBK1 signaling away from IRF3-dependent type I interferon production and toward incomplete autophagy. Its combination of molecular interaction studies, pharmacologic perturbation, animal models, and patient tissues links HBsAg-driven immune suppression with HBV persistence.
-
NMDAR–Connexin Signaling in TMJ Inflammatory Pain
2026-08-13
This study identifies a mechanistic connection between GluN2A/GluN2B-containing NMDARs and connexin- or pannexin-mediated communication in the trigeminal ganglion during TMJ inflammation. Its genetic, behavioral, cellular, and signaling data indicate that the two NMDAR subunits contribute differently to peripheral sensitization and may provide distinct targets for orofacial inflammatory pain research.
-
Cell Lysis Buffer for WB and IP in CAF Research
2026-08-13
Cell lysis buffer for WB and IP can do more than support routine protein extraction. This article presents a compartment-aware workflow for studying CAF-driven ANGPTL4–IQGAP1 signaling, chemoresistance, and mitochondrial adaptation while preserving both protein abundance and native interactions.
-
Spermine in Membrane and Viral Egress Assays
2026-08-12
Spermine is an endogenous polyamine with powerful effects on ion channel regulation and cellular physiology. This guide shows how to use it as a controlled assay variable while interpreting CLCC1-dependent herpesvirus nuclear egress without assuming an unproven direct mechanism.